190 related articles for article (PubMed ID: 15030982)
41. Histocompatibility antigens in patients with hepatocellular carcinoma.
Golubovic G; Stajic M; Stolic I; Nikolic JA; Neskovic AN; Pandey L
Z Gastroenterol; 1996 Jan; 34(1):15-20. PubMed ID: 8776170
[TBL] [Abstract][Full Text] [Related]
42. Clustering of different subtypes of hepatitis B surface antigen in families of patients with chronic liver diseases.
Sung JL; Chen DS
Am J Gastroenterol; 1978 May; 69(5):559-64. PubMed ID: 210659
[TBL] [Abstract][Full Text] [Related]
43. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF
Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
45. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
[TBL] [Abstract][Full Text] [Related]
46. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
47. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
48. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
49. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
[TBL] [Abstract][Full Text] [Related]
50. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
51. [A case-control study on HBV infection in families of hepatocellular carcinoma-application of conditional logistic regression model].
Chen J
Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Aug; 12(4):208-12. PubMed ID: 1657396
[TBL] [Abstract][Full Text] [Related]
52. Risk and predictors of mortality associated with chronic hepatitis B infection.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
[TBL] [Abstract][Full Text] [Related]
53. [Unscheduled DNA synthesis of peripheral blood lymphocytes in pedigrees of hepatocellular carcinoma patients].
Wang JB
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):325-7. PubMed ID: 1664315
[TBL] [Abstract][Full Text] [Related]
54. Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis.
Yeh SH; Chang CF; Shau WY; Chen YW; Hsu HC; Lee PH; Chen DS; Chen PJ
Cancer Res; 2002 Aug; 62(15):4346-51. PubMed ID: 12154039
[TBL] [Abstract][Full Text] [Related]
55. Etiological factor of hepatocellular carcinoma in Italy.
Stroffolini T
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
[TBL] [Abstract][Full Text] [Related]
56. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.
Sung FY; Jung CM; Wu CF; Lin CL; Liu CJ; Liaw YF; Tsai KS; Yu MW
Gastroenterology; 2009 Nov; 137(5):1687-97. PubMed ID: 19664630
[TBL] [Abstract][Full Text] [Related]
58. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
59. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
[TBL] [Abstract][Full Text] [Related]
60. Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.
Kiyici M; Yilmaz M; Akyildiz M; Arikan C; Aydin U; Sigirli D; Nart D; Yilmaz F; Ozacar T; Karasu Z; Kilic M
Transplant Proc; 2008 Jun; 40(5):1511-7. PubMed ID: 18589140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
